436 related articles for article (PubMed ID: 33253055)
1. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
Denee T; Ming T; Waller J; Bailey T; Rajkovic-Hooley O; Middleton-Dalby C; Le HH; Zhang Q; McCrone P; Taylor D
Curr Med Res Opin; 2021 Feb; 37(2):311-319. PubMed ID: 33253055
[TBL] [Abstract][Full Text] [Related]
2. Economic Burden of Treatment-Resistant Depression on the U.S. Health Care System.
Sussman M; O'sullivan AK; Shah A; Olfson M; Menzin J
J Manag Care Spec Pharm; 2019 Jul; 25(7):823-835. PubMed ID: 31232205
[TBL] [Abstract][Full Text] [Related]
3. Descriptive analysis of the economic burden of treatment resistance in a major depressive episode.
Cai Q; Sheehan JJ; Wu B; Alphs L; Connolly N; Benson C
Curr Med Res Opin; 2020 Feb; 36(2):329-335. PubMed ID: 31540559
[No Abstract] [Full Text] [Related]
4. Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions.
Zhdanava M; Kuvadia H; Joshi K; Daly E; Pilon D; Rossi C; Morrison L; Lefebvre P; Nelson C
J Manag Care Spec Pharm; 2020 Aug; 26(8):996-1007. PubMed ID: 32552362
[TBL] [Abstract][Full Text] [Related]
5. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
[TBL] [Abstract][Full Text] [Related]
6. Prospective Service Use and Health Care Costs of Medicaid Beneficiaries with Treatment-Resistant Depression.
Olfson M; Amos TB; Benson C; McRae J; Marcus SC
J Manag Care Spec Pharm; 2018 Mar; 24(3):226-236. PubMed ID: 29485948
[TBL] [Abstract][Full Text] [Related]
7. Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?
Pilon D; Sheehan JJ; Szukis H; Morrison L; Zhdanava M; Lefebvre P; Joshi K
J Affect Disord; 2019 Aug; 255():50-59. PubMed ID: 31128505
[TBL] [Abstract][Full Text] [Related]
8. Use of home health and other healthcare delivery pathways among privately insured patients with and without treatment-resistant depression.
Pilon D; Szukis H; Singer D; Morrison L; Sheehan JJ; Lefebvre P
Curr Med Res Opin; 2020 May; 36(5):865-874. PubMed ID: 31985319
[No Abstract] [Full Text] [Related]
9. Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization.
Heerlein K; De Giorgi S; Degraeve G; Frodl T; Hagedoorn W; Oliveira-Maia AJ; Otte C; Perez Sola V; Rathod S; Rosso G; Sierra P; Vita A; Morrens J; Rive B; Mulhern Haughey S; Kambarov Y; Young AH
J Affect Disord; 2022 Feb; 298(Pt A):442-450. PubMed ID: 34742998
[TBL] [Abstract][Full Text] [Related]
10. Treatment-resistant depression increases health costs and resource utilization.
Lepine BA; Moreno RA; Campos RN; Couttolenc BF
Braz J Psychiatry; 2012 Dec; 34(4):379-88. PubMed ID: 23429808
[TBL] [Abstract][Full Text] [Related]
11. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
[TBL] [Abstract][Full Text] [Related]
12. An Evaluation of the Clinical and Economic Burden Among Older Adult Medicare-Covered Beneficiaries With Treatment-Resistant Depression.
Benson C; Szukis H; Sheehan JJ; Alphs L; Yuce H
Am J Geriatr Psychiatry; 2020 Mar; 28(3):350-362. PubMed ID: 31735488
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.
Li G; Zhang L; DiBernardo A; Wang G; Sheehan JJ; Lee K; Reutfors J; Zhang Q
PLoS One; 2020; 15(9):e0238843. PubMed ID: 32915863
[TBL] [Abstract][Full Text] [Related]
14. Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder.
Ta JT; Sullivan SD; Tung A; Oliveri D; Gillard P; Devine B
J Manag Care Spec Pharm; 2021 Feb; 27(2):223-239. PubMed ID: 33506730
[No Abstract] [Full Text] [Related]
15. Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database.
Amos TB; Tandon N; Lefebvre P; Pilon D; Kamstra RL; Pivneva I; Greenberg PE
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29474009
[TBL] [Abstract][Full Text] [Related]
16. The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis.
Culpepper L; Martin A; Nabulsi N; Parikh M
Adv Ther; 2024 May; 41(5):1860-1884. PubMed ID: 38466558
[TBL] [Abstract][Full Text] [Related]
17. The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States.
Zhdanava M; Pilon D; Ghelerter I; Chow W; Joshi K; Lefebvre P; Sheehan JJ
J Clin Psychiatry; 2021 Mar; 82(2):. PubMed ID: 33989464
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Relationship Between Depression Symptom Severity and Health Care Costs for Patients With Treatment-Resistant Depression.
Lynch FL; Dickerson JF; O'Keeffe-Rosetti M; Chow W; Pesa J
J Clin Psychiatry; 2022 Feb; 83(2):. PubMed ID: 35120286
[No Abstract] [Full Text] [Related]
19. Economic impact of treatment-resistant depression: A retrospective observational study.
Pérez-Sola V; Roca M; Alonso J; Gabilondo A; Hernando T; Sicras-Mainar A; Sicras-Navarro A; Herrera B; Vieta E
J Affect Disord; 2021 Dec; 295():578-586. PubMed ID: 34509073
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and economic burden of treatment-resistant depression in Thailand.
Prasartpornsirichoke J; Pityaratstian N; Poolvoralaks C; Sirinimnualkul N; Ormtavesub T; Hiranwattana N; Phonsit S; Rungnirundorn T
BMC Public Health; 2023 Aug; 23(1):1541. PubMed ID: 37573321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
